Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Quality of prostate cancer screening information on the websites of nationally recognized cancer centers and health organizations.

Manole BA, Wakefield DV, Dove AP, Dulaney CR, Marcrom SR, Schwartz DL, Farmer MR.

Pract Radiat Oncol. 2018 Jul - Aug;8(4):275-278. doi: 10.1016/j.prro.2017.12.010. Epub 2017 Dec 24.

PMID:
29452874
2.

Accessibility, availability, and quality of online information for US radiation oncology residencies.

Wakefield DV, Manole BA, Jethanandani A, May ME Jr, Marcrom SR, Farmer MR, Ballo MT, VanderWalde NA.

Pract Radiat Oncol. 2016 May-Jun;6(3):160-165. doi: 10.1016/j.prro.2015.10.016. Epub 2015 Oct 29.

PMID:
26723548
3.

Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer.

Blackstock AW, Aklilu M, Lovato J, Farmer MR, Mishra G, Melin SA, Oaks T, Geisinger K, Levine EA.

Int J Gastrointest Cancer. 2006;37(1):7-14.

PMID:
17290076
4.
5.

A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer.

Blackstock AW, Farmer MR, Lovato J, Mishra G, Melin SA, Oaks T, Aklilu M, Clark PB, Levine EA.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):455-60. Epub 2005 Oct 5.

PMID:
16213103
6.

E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells.

Elliott MJ, Farmer MR, Atienza C Jr, Stilwell A, Dong YB, Yang HL, Wong SL, McMasters KM.

Tumour Biol. 2002 Mar-Apr;23(2):76-86.

PMID:
12065845

Supplemental Content

Loading ...
Support Center